Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00061880
Status:
COMPLETED
Last Update Posted:
2013-05-30
First Post:
2003-06-05
Brief Title:
BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell Lymphoma
Sponsor:
BioCryst Pharmaceuticals
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
BIOCRYST-1777BC-103
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BioCryst Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None